Veracyte (VCYT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VCYT Veracyte

Watchlist

40.120
-0.830-2.03%

Close Dec 27 16:00 ET

39.880
-0.240-0.60%

Post 18:44 ET

3.11BMarket Cap-308.62P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Breakeven Is Near for Veracyte, Inc. (NASDAQ:VCYT)
Simply Wall StDec 23 12:15 ET
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
Zacks Dec 19 12:00 ET
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
Zacks Dec 16 10:25 ET
Express News | Veracyte Inc : Guggenheim Raises Target Price to $45 From $40
ReutersDec 16 07:17 ET
Those Who Invested in Veracyte (NASDAQ:VCYT) a Year Ago Are up 68%
Yahoo FinanceDec 11 13:14 ET
If You Invested $1000 in Veracyte a Decade Ago, This Is How Much It'd Be Worth Now
Zacks Dec 11 07:35 ET

Comments

Stock_Drift

Sep 15 09:56

$Veracyte (VCYT.US)$

ClydePeternuts

Sep 12 02:17

Cathie Wood and Ark Invest's trade activity from today 9/10
$ARK Innovation ETF (ARKK.US)$ :
Bought $Advanced Micro Devices (AMD.US)$ $DraftKings (DKNG.US)$ $Tempus AI (TEM.US)$
Sold $Unity Software (U.US)$ $Palantir (PLTR.US)$ $Twist Bioscience (TWST.US)$ $Veracyte (VCYT.US)$
By the way..
Palantir $PLTR is on fire this year
It's up over 109% YTD, just got included in the S&P500, and today Bank of America raised their price target to $50 a share
D. E. Shaw owns almost $500 million worth of shares, more than any...

Moomoo AI

Feb 24 08:25

Analysts are slightly more optimistic about Veracyte's losses per share, but expect its revenue growth to slow down substantially compared to its historical 29% growth rate. The wider industry is expected to outpace Veracyte.

Veracyte, Inc. (NASDAQ:VCYT) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Moomoo AI

Oct 28, 2023 08:07

The absence of any insider transactions in the past three months doesn't reveal much. Low insider ownership and previous insider selling at Veracyte sparks less enthusiasm. Investors should be aware of potential risks associated with the company.